Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells
- 1 December 1995
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 3 (4) , 313-320
- https://doi.org/10.1016/0966-3274(95)80017-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- In vitro inhibition of human cytomegalovirus replication by desferrioxamineAntiviral Research, 1994
- THE ANTIMICROBIAL ACTIVITIES OF CYCLOSPORINE, FK506, AND RAPAMYCINTransplantation, 1994
- A PHASE I TRIAL OF IMMUNOSUPPRESSION WITH ANTIIC AM-1 (CD54) mAb IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- Lymphocyte interactions with endothelial cellsImmunology Today, 1992
- Cytomegalovirus- and interferon-related effects on human endothelial cells: Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-γHuman Immunology, 1992
- Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1Science, 1992
- Lymphocyte Migration Patterns in Organ Allograft RecipientsImmunological Reviews, 1989
- Desferrioxamine treatment prevents chronic islet allograft damageDiabetes, 1986
- Iron and Deferoxamine in Lymphocyte BlastogenesisJournal of Immunopharmacology, 1980
- Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical ProgressBMJ, 1974